Results 11 to 20 of about 48,011 (239)

Platelet Transfusion Refractoriness

Plasmatology
Platelet transfusion refractoriness (PTR) is a conditioikb1n where platelet counts fail to increase adequately in several transfusions, often found in hemato-oncological situations.
Anna Mira Lubis MD, Muhammad Orri Baskoro MD, Amirah Yasmin MD   +2 more
doaj   +3 more sources

Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases

Platelets, 2023
Platelet transfusion refractoriness (PTR) is an intractable issue in hematological patients, which increases bleeding risks and hospitalization costs to a great extent.
Jiaqian Qi, Yue Han
exaly   +3 more sources

Prevalence of risk factors for platelet transfusion refractoriness in multitransfused hemato-oncological patients at tertiary care center in North India

Asian Journal of Transfusion Science, 2015
Background: This study was designed to determine the prevalence and assess the risk factors responsible for platelet transfusion refractoriness in hemato-oncological patients. Materials and Methods: The study included 30 patients.
Vijay Kumawat, Ratti Ram Sharma, Pankaj Malhotra, Neelam Marwaha   +3 more
doaj   +3 more sources

Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy

Leukemia Research, 2017
International audiencePlatelet transfusion refractoriness (PTR) is a major adverse event in the management of acute myeloid leukemia (AML). In a series of 897 adult patients with AML receiving intensive chemotherapy, we identified 41 patients (4.8%) with
Suzanne Tavitian, Emilie Berard, Eric Delabesse   +2 more
exaly   +3 more sources

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia [PDF]

Cancer Medicine, 2020
Platelet transfusion is important in the prevention and treatment of bleeding in patients with acute myeloid leukemia (AML) after receiving intensive chemotherapy.
Xuelian Hu, Haodong Cai, Yi Luo
exaly   +3 more sources

Platelet transfusion refractoriness [PDF]

British Journal of Haematology, 2008
SummaryThe platelet, a fascinating anucleate cell, is critically important for haemostasis. Platelet transfusions have greatly reduced the incidence of major haemorrhagic complications associated with the management of haematological and oncological disorders. However, some patients fail to receive the full benefit of platelet transfusions because they
Eldad A Hod, Joseph E Schwartz
exaly   +3 more sources

Identification of platelet refractoriness in oncohematologic patients [PDF]

Clinics, 2011
OBJECTIVES: To identify the occurrence and the causes of platelet refractoriness in oncohematologic patients. INTRODUCTION: Platelet refractoriness (unsatisfactory post-transfusion platelet increment) is a severe problem that impairs the treatment of ...
Aline Aparecida Ferreira, Roberto Zulli, Sheila Soares, Vagner de Castro, Helio Moraes-Souza   +4 more
doaj   +2 more sources

Mechanism and transfusion strategy of immunogenic platelet transfusion refractoriness

Zhongguo shuxue zazhi, 2022
Platelet transfusion is an irreplaceable method to treat patients with platelet reduction in Hematology Department and Oncology Department. However, immunogenic platelet transfusion refractoriness is a huge challenge to patients who require repeatedly ...
Juan SAI, Li TIAN
doaj   +2 more sources

Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim

Transfusion and Apheresis Science, 2022
Immune-mediated platelet transfusion refractoriness due to anti-human leukocyte antigen (HLA) antibodies can occur in approximately 9% of patients with myelodysplastic syndromes (MDS) and can lead to an increased risk of clinically relevant bleeds ...
Čengić, Marina, Skorić, Ivana, Ivana Skorić, Ivan Krečak, Marina Čengić, Filip Krečak, Skelin, Marko, Marko Skelin, Krečak, Ivan, Krečak, Filip   +9 more
core   +2 more sources

Severe platelet transfusion refractoriness after thoracoabdominal aneurysm repair [PDF]

Journal of Vascular Surgery Cases and Innovative Techniques
Severe thrombocytopenia after thoracoabdominal aortic aneurysm repair poses a significant clinical risk in the immediate postoperative period.
Claire M. Motyl, MD, S. Danielle Phillips, AGACNP-BC, RNFA, Jori E. May, MD, Adam W. Beck, MD   +3 more
doaj   +2 more sources